指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

急诊科老年成人谵妄临床实践指南的批判性评价与推荐意见整合:一项伞状综述

A critical appraisal and recommendation synthesis of delirium clinical practice guidelines relevant to the care of older adults in the emergency department: An umbrella review.
指南 / 共识 · J Eval Clin Pract · 2023-06-14
一句话结论尽管无急诊科专用谵妄指南,高质量指南一致推荐对高危老年急诊患者用4A's Test筛查谵妄,并采用多组分策略预防和管理。

该伞状综述检索并批判性评价了与急诊科老年患者谵妄照护相关的临床实践指南,使用AGREE-II和AGREE-REX工具评价质量。10部指南中仅5部达到AGREE-II严谨性发展领域≥70%的高质量阈值,其推荐被纳入整合。推荐涵盖筛查、诊断、风险降低和管理:一致认为应筛查不可调控危险因素以定义高危人群,并对高危者筛查谵妄;急诊科推荐使用4A's Test工具;推荐多组分策略降低谵妄风险及管理谵妄。唯一分歧在于紧急情况下短期使用抗精神病药物。

要点

  • 10部指南中仅5部AGREE-II严谨性发展评分≥70%被纳入推荐整合,AGREE-II该领域评分范围37%~83%。
  • 指南一致认为应筛查不可调控危险因素以识别高危老年患者,并对高危者进行谵妄筛查。
  • 急诊科推荐使用4A's Test作为谵妄筛查工具。
  • 推荐采用多组分策略降低谵妄风险,并在谵妄发生后用于管理。
  • 唯一分歧为紧急情况下短期使用抗精神病药物。

适用人群与场景

  • 急诊科老年成人,尤其存在不可调控危险因素的高危人群。

诊断标准与关键阈值

  • 使用AGREE-II严谨性发展领域≥70%作为高质量指南的预设阈值。

处置流程与药物剂量

  • 推荐筛查不可调控危险因素以定义高危人群,并对高危者筛查谵妄。
  • 急诊科推荐使用4A's Test工具筛查谵妄。
  • 推荐多组分策略用于降低谵妄风险,以及谵妄发生后的管理。

研究设计与关键结果

  • 伞状综述共纳入10部临床实践指南,AGREE-II严谨性发展评分范围37%~83%,5部达到≥70%阈值。
  • AGREE-REX总体计算评分范围44%~80%。
  • 纳入指南均非急诊科专用,但许多推荐整合了急诊科证据。
  • 推荐被归为筛查、诊断、风险降低和管理四类。
  • 唯一分歧为紧急情况下短期使用抗精神病药物。

证据类型、等级与局限

  • 证据类型:伞状综述,对临床实践指南进行批判性评价与推荐意见整合。
  • 质量评价工具:AGREE-II和AGREE-REX。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在急诊科对老年患者应筛查不可调控危险因素以识别谵妄高危人群,并对高危者使用4A's Test筛查谵妄。
  • 对急诊科老年患者可采用多组分策略降低谵妄风险,并在谵妄发生后用于管理。
  • 紧急情况下短期使用抗精神病药物是指南间唯一存在分歧的领域。

指南或共识出处

  • 与急诊科老年成人谵妄照护相关的临床实践指南(共10部,均非急诊科专用)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Older adults are at high risk of developing delirium in the emergency department (ED); however, it is often missed or undertreated. Improving ED delirium care is challenging in part due to a lack of standards to guide best practice. Clinical practice guidelines (CPGs) translate evidence into recommendations to improve practice.

AIM: To critically appraise and synthesize CPG recommendations for delirium care relevant to older ED patients.

METHODS: We conducted an umbrella review to retrieve relevant CPGs. Quality of the CPGs and their recommendations were critically appraised using the Appraisal of Guidelines, Research, and Evaluation (AGREE)-II; and Appraisal of Guidelines Research and Evaluation-Recommendations Excellence (AGREE-REX) instruments. A threshold of 70% or greater in the AGREE-II Rigour of Development domain was used to define high-quality CPGs. Delirium recommendations from CPGs meeting this threshold were included in the synthesis and narrative analysis.

RESULTS: AGREE-II Rigour of Development scores ranged from 37% to 83%, with 5 of 10 CPGs meeting the predefined threshold. AGREE-REX overall calculated scores ranged from 44% to 80%. Recommendations were grouped into screening, diagnosis, risk reduction, and management. Although none of the included CPGs were ED-specific, many recommendations incorporated evidence from this setting. There was agreement that screening for nonmodifiable risk factors is important to define high-risk populations, and those at risk should be screened for delirium. The '4A's Test' was the recommended tool to use in the ED specifically. Multicomponent strategies were recommended for delirium risk reduction, and for its management if it occurs. The only area of disagreement was for the short-term use of antipsychotic medication in urgent situations.

CONCLUSION: This is the first known review of delirium CPGs including a critical appraisal and synthesis of recommendations. Researchers and policymakers can use this synthesis to inform future improvement efforts and research in the ED.

REGISTRATION: This study has been registered in the Open Science Framework registries: https://doi.org/10.17605/OSF.IO/TG7S6OSF.IO/TG7S6.

来源:J Eval Clin Pract,查看原文。版权归原作者所有。

参考来源

  1. Filiatreault S, Grimshaw JM, Kreindler SA, et al. A critical appraisal and recommendation synthesis of delirium clinical practice guidelines relevant to the care of older adults in the emergency department: An umbrella review. J Eval Clin Pract. 2023. PMID: 37316463. doi:10.1111/jep.13883

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。